Results 181 to 190 of about 102,885 (334)
Case of Urticaria Pigmentosa with Bullous Lesions. [PDF]
J. M. H. MacLeod
openalex +1 more source
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki +24 more
wiley +1 more source
Circulating vitamin D concentrations and the risk of urticaria: A bidirectional two-sample Mendelian randomization study. [PDF]
Chai HX, Wang F, Liu H, Xie YQ, Zhou ZH.
europepmc +1 more source
Case of Urticaria Pigmentosa without Mast Cells [PDF]
E. G. Graham Little
openalex +1 more source
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory disease characterized by recurrent remissions and relapses. Topical anti‐inflammatory steroids are commonly used for treatment, but their long‐term use poses concerns because of potential side effects. Delgocitinib ointment, a Janus kinase inhibitor, has demonstrated efficacy in several clinical
Masatoshi Abe +5 more
wiley +1 more source
Antibodies IgA, IgE, IgM, and IgG Reactivities Against Two Species of <i>Anisakis</i> in Three Cases of Anisakis Allergy. [PDF]
Kondo M, Habe K, Yamanaka K.
europepmc +1 more source
ABSTRACT Chronic spontaneous urticaria (CSU) affects 0.5%–1.0% of the population worldwide. However, information on the prevalence, comorbidities, and treatment patterns of CSU in Japan is limited. This observational study consisted of a cross‐sectional and longitudinal part.
Atsushi Fukunaga +3 more
wiley +1 more source
Knowledge, Attitude, and Practice Towards Urticaria in an Online Sample of the Chinese General Population. [PDF]
Liu Y +5 more
europepmc +1 more source

